MAPS receives first-ever government funding and waits for NIDA marijuana CONTACT: Brad Burge, MAPS Media Requests: Press Resources: Sue Sisley, M.D. suesisley@aol.com DENVER, COLO.—On Wednesday, December …
November 15, 2014 CONTACT: Brad Burge, MAPS Director of Communications and Marketing Media Requests: Press Resources: MAPS Hosts Lecture, Reception, and Dinner November 13 and 15 in Los Angeles Culver …
On October 23, 2014, the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization, will present a lecture on MDMA-assisted therapies to treat post-traumatic …
MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD) researchers Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., will speak in Dallas on September 8, 2014. Contact: Virginia Wright, …
On August 11, the Multidisciplinary Association for Psychedelic Studies (MAPS) launched its boldest crowdfunding campaign yet. In just 16 days, the Legalizing Psychedelic Therapy campaign on Indiegogo …
A petition launched on Change.org by an Arizona veteran has gathered over 100,000 signatures in support of Dr. Sue Sisley’s efforts to initiate medical marijuana research in Arizona. Launched on …
On July 28, 2014, the University of Arizona denied Dr. Sue Sisley’s administrative appeal for reinstatement (view the letter). Update (July 31, 2014): The Arizona Board of Regents has announced that …
On Tuesday, July 22, at 12:00 pm, a group of veterans will assemble at the University of Arizona College of Medicine-Phoenix to demand the reinstatement of Dr. Sue Sisley, which will enable FDA-approved …
MAPS “PRESS RELEASE: Letter from Rick Doblin to University of Arizona in Support of Dr. Sue Sisley” On July 11, 2014, MAPS Founder Rick Doblin, Ph.D., wrote to Caroline Garcia, Associate Vice …
MAPS, DPA On Wednesday, June 11, the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Drug Policy Alliance (DPA) will hold a press teleconference to accompany the release of their new …
Funding for research into the therapeutic uses of psychedelics and medical marijuana increased significantly this April, when the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) …
After 22 years of hard-fought efforts, the non-profit pharmaceutical company Multidisciplinary Association for Psychedelic Studies (MAPS) has finally obtained approval from the U.S. Department of Health …
